PHARMACOKINETIC VARIABILITY AND THERAPEUTIC DRUG MONITORING OF SYSTEMIC ANTIFUNGAL AGENTS: MITIGATING HEPATOTOXICITY AND OPTIMIZING EFFICACY IN CRITICALLY ILL COHORTS. Wor.Bul.Pub.Helt. [Internet]. 2026 Mar. 26 [cited 2026 Apr. 18];56:85-8. Available from: https://www.scholarexpress.net/index.php/wbph/article/view/5984